Low Molecular Weight Heparin Market - by Drug Type (Enoxaparin, Dalteparin, Tinzaparin, and Others), by Application (Venous Thromboembolism, Myocardial Infraction, Complicated Pregnancies, Cardioversion of Atrial Fibrillation, and Others), and by Distribu

Low Molecular Weight Heparin Market - by Drug Type (Enoxaparin, Dalteparin, Tinzaparin, and Others), by Application (Venous Thromboembolism, Myocardial Infraction, Complicated Pregnancies, Cardioversion of Atrial Fibrillation, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis 2017-2025

Low Molecular Weight Heparin (LMWH) has several advantages over other heparin such as longer and more predictable activity than Unfractionated Heparin (UFH) and can be self-administrated at home via subcutaneous injection, reducing or eliminating hospital stays, thereby no regular blood monitoring required. Furthermore, heparins do not cross the placenta or harm the fetus, so they are the preferred anticoagulants for pregnant women who experience or who are at heightened risk of – blood clots. These advantages make LMWH as the most preferred heparin in inhibiting clotting factors.

Market Dynamics

Increasing number of people are being affected with Deep Vein Thrombosis (DVT) which will subsequently increase demand for LMWH. For instance, according to National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), February 2018; the precise number of people affected by DVT/PE is unknown, although as many as 900,000 people could be affected (1 to 2 per 1,000) each year in the U.S.

Furthermore, increasing engagement of government healthcare regulatory bodies in developing and delivering effective and cost-effective low molecular weight heparin molecule products in the market is expected to propel the growth of the market. For instance, in 2014, American Society of Health-System Pharmacists (ASHP) issued the policy for safe and effective use of heparin in neonatal patients thereby supporting the development and use of nationally standardized concentrations of heparin when used for maintenance and flush of peripheral and central venous lines in neonatal patients.

Key features of the study:

  • This report provides in-depth analysis of low molecular weight heparin market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, low molecular weight heparin approval & launch, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global low molecular weight heparin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
  • Key companies covered as part of this study include, Pfizer, Inc., LEO Pharma A/S, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Amphastar Pharmaceuticals Inc., Abbott Laboratories, Aspen Pharmacare Holdings, Laboratorios Farmaceuticos ROVI SA, Changzhou Qianhong Biopharma, and Intrapharm Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future drug launch, manufacturing up-gradation, market expansion, and marketing tactics
  • The global low molecular weight heparin market report caters to various stakeholders in this industry including investors, suppliers, low molecular weight heparin based product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the low molecular weight heparin market.
Detailed Segmentation:
  • Global Low Molecular Weight Heparin Market, By Drug:
  • Enoxaparin
  • Dalteparin
  • Nadroparin
  • Bemiparin
  • Tinzaparin
  • Others
  • Global Low Molecular Weight Heparin Market, By Packaging:
  • Multi-vials
  • Prefilled Syringes
  • Global Low Molecular Weight Heparin Market, By Application:
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome (ACS)
  • Pulmonary Embolism
  • Atrial Fibrillation
  • Global Low Molecular Weight Heparin Market, By End Use:
  • Hospitals
  • Private
  • Public
  • Clinics
  • Home
  • Global Low Molecular Weight Heparin Market, By Geography:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Drug:
  • Enoxaparin
  • Dalteparin
  • Nadroparin
  • Bemiparin
  • Tinzaparin
  • Others
  • By Packaging
  • Multi-vials
  • Prefilled Syringes
  • By Application:
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome (ACS)
  • Pulmonary Embolism
  • Atrial Fibrillation
  • By End Use:
  • Hospitals
  • Private
  • Public
  • Clinics
  • Home
  • Europe
  • By Country:
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Russia
  • Rest of Europe
  • By Drug:
  • Enoxaparin
  • Dalteparin
  • Nadroparin
  • Bemiparin
  • Tinzaparin
  • Others
  • By Packaging
  • Multi-vials
  • Prefilled Syringes
  • By Application:
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome (ACS)
  • Pulmonary Embolism
  • Atrial Fibrillation
  • By End Use:
  • Hospitals
  • Private
  • Public
  • Clinics
  • Home
  • Asia Pacific
  • By Country:
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • By Drug:
  • Enoxaparin
  • Dalteparin
  • Nadroparin
  • Bemiparin
  • Tinzaparin
  • Others
  • By Packaging
  • Multi-vials
  • Prefilled Syringes
  • By Application:
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome (ACS)
  • Pulmonary Embolism
  • Atrial Fibrillation
  • By End Use:
  • Hospitals
  • Private
  • Public
  • Clinics
  • Home
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Drug:
  • Enoxaparin
  • Dalteparin
  • Nadroparin
  • Bemiparin
  • Tinzaparin
  • Others
  • By Packaging
  • Multi-vials
  • Prefilled Syringes
  • By Application:
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome (ACS)
  • Pulmonary Embolism
  • Atrial Fibrillation
  • By End Use:
  • Hospitals
  • Private
  • Public
  • Clinics
  • Home
  • Latin America
  • By Country:
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • By Drug:
  • Enoxaparin
  • Dalteparin
  • Nadroparin
  • Bemiparin
  • Tinzaparin
  • Others
  • By Packaging
  • Multi-vials
  • Prefilled Syringes
  • By Application:
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome (ACS)
  • Pulmonary Embolism
  • Atrial Fibrillation
  • By End Use:
  • Hospitals
  • Private
  • Public
  • Clinics
  • Home
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Drug:
  • Enoxaparin
  • Dalteparin
  • Nadroparin
  • Bemiparin
  • Tinzaparin
  • Others
  • By Packaging
  • Multi-vials
  • Prefilled Syringes
  • By Application:
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome (ACS)
  • Pulmonary Embolism
  • Atrial Fibrillation
  • By End Use:
  • Hospitals
  • Private
  • Public
  • Clinics
  • Home
  • Company Profiles
  • Pfizer, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments
  • Strategies
  • LEO Pharma A/S
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Amphastar Pharmaceuticals Inc.
  • Abbott Laboratories
  • Aspen Pharmacare Holdings
  • Laboratorios Farmaceuticos ROVI SA
  • Changzhou Qianhong Biopharma
  • Intrapharm Laboratories
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug
Market Snippet, By Packaging
Market Snippet, By Application
Market Snippet, By End Use
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Epidemiology
Key Developments
Strategic Acquisitions
Advantages of LMWH over UFH
Cost-effectiveness of LMWH vs. UFH
Shortage of Enoxaparin & Estimated Resupply Dates
Drug Delivery Systems
Regulatory Scenario
Reimbursement Scenario
Buy-and-bill and White Bagging Channel
PEST Analysis
4. Global Low Molecular Weight Heparin Market, By Drug, 2018 - 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 - 2026
Segment Trends
Enoxaparin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Dalteparin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Nadroparin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Bemiparin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Tinzaparin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
5. Global Low Molecular Weight Heparin Market, By Packaging, 2018 - 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 - 2026
Segment Trends
Multi-vials
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Prefilled Syringes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
6. Global Low Molecular Weight Heparin Market, By Application, 2018 - 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 - 2026
Segment Trends
Deep Vein Thrombosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Acute Coronary Syndrome (ACS)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Pulmonary Embolism
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Atrial Fibrillation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
7. Global Low Molecular Weight Heparin Market, By End Use, 2018 - 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 - 2026
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Private
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Public
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
Home
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
8. Global Low Molecular Weight Heparin Market, By Region, 2018 - 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 - 2026
North America
Market Size and Forecast, By Drug, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Packaging, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
Market Size and Forecast, By End Use, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Drug, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Packaging, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
Market Size and Forecast, By End Use, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Packaging, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
Market Size and Forecast, By End Use, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Drug, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Packaging, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
Market Size and Forecast, By End Use, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Packaging, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
Market Size and Forecast, By End Use, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Drug, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Packaging, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
Market Size and Forecast, By End Use, 2018 - 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
9. Competitive Landscape
Heat Map Analysis
Company Profiles
Pfizer, Inc.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
LEO Pharma A/S
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
Sanofi S.A.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
Amphastar Pharmaceuticals Inc.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
Aspen Pharmacare Holdings
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
Laboratorios Farmaceuticos ROVI SA
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
Changzhou Qianhong Biopharma
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
Intrapharm Laboratories
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
Abbott Laboratories
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
10. Section
References
Research Methodology
About Us and Sales Contact
*Browse 44 market data tables and 39 figures on "Low Molecular Weight Heparin Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook